Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Kanzler

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
BMC Cancer|July 19, 2006
Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case reportMartin F Sprinzl, Carl C Schimanski, Markus Moehler, et al.
Autoimmunity|May 27, 2003
Prevalence of autoantibodies to the p53 protein in autoimmune hepatitisJohannes Herkel, Jan-Philip Modrow, Sonja Bamberger, et al.
World Journal of Gastroenterology|September 29, 2006
Genetic association of autoimmune hepatitis and human leucocyte antigen in German patientsAndreas Teufel, Markus Wörns, Arndt Weinmann, et al.
Journal of Hepatology|July 13, 2004
Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failureCarl C Schimanski, Jürgen Burg, Markus Möhler, et al.
Journal of Clinical Gastroenterology|July 23, 2008
Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitisStefan Lüth, Johannes Herkel, Stephan Kanzler, et al.
Molecular Carcinogenesis|June 18, 2011
Liver-specific overexpression of matrix metalloproteinase 9 (MMP-9) in transgenic mice accelerates development of hepatocellular carcinomaFlorian R Thieringer, Thorsten Maass, Bianca Anthon, et al.
Cancer Research|January 15, 2009
IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53Kerstin Herzer, Thomas G Hofmann, Andreas Teufel, et al.
The American Journal of Gastroenterology|June 23, 2006
Five cases of de novo inflammatory bowel disease after orthotopic liver transplantationMarcus A Wörns, Ansgar W Lohse, Markus F Neurath, et al.
The American Journal of Gastroenterology|November 1, 2007
Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseasesMarcus A Wörns, Andreas Teufel, Stephan Kanzler, et al.
Journal of Hepatology|September 11, 2010
Liver-specific Ldb1 deletion results in enhanced liver cancer developmentAndreas Teufel, Thorsten Maass, Susanne Strand, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
BMC Cancer|July 19, 2006
Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case reportMartin F Sprinzl, Carl C Schimanski, Markus Moehler, et al.
Autoimmunity|May 27, 2003
Prevalence of autoantibodies to the p53 protein in autoimmune hepatitisJohannes Herkel, Jan-Philip Modrow, Sonja Bamberger, et al.
World Journal of Gastroenterology|September 29, 2006
Genetic association of autoimmune hepatitis and human leucocyte antigen in German patientsAndreas Teufel, Markus Wörns, Arndt Weinmann, et al.
Journal of Hepatology|July 13, 2004
Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failureCarl C Schimanski, Jürgen Burg, Markus Möhler, et al.
Journal of Clinical Gastroenterology|July 23, 2008
Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitisStefan Lüth, Johannes Herkel, Stephan Kanzler, et al.
Molecular Carcinogenesis|June 18, 2011
Liver-specific overexpression of matrix metalloproteinase 9 (MMP-9) in transgenic mice accelerates development of hepatocellular carcinomaFlorian R Thieringer, Thorsten Maass, Bianca Anthon, et al.
Cancer Research|January 15, 2009
IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53Kerstin Herzer, Thomas G Hofmann, Andreas Teufel, et al.
The American Journal of Gastroenterology|June 23, 2006
Five cases of de novo inflammatory bowel disease after orthotopic liver transplantationMarcus A Wörns, Ansgar W Lohse, Markus F Neurath, et al.
The American Journal of Gastroenterology|November 1, 2007
Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseasesMarcus A Wörns, Andreas Teufel, Stephan Kanzler, et al.
Journal of Hepatology|September 11, 2010
Liver-specific Ldb1 deletion results in enhanced liver cancer developmentAndreas Teufel, Thorsten Maass, Susanne Strand, et al.
Pageof 5